Unmet clinical needs in the treatment of systemic fungal infections: The role of amphotericin B and drug targeting.
about
Amphotericin B, an Anti-Fungal Medication, Directly Increases the Cytotoxicity of NK Cells.Nebulised antibiotherapy: conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?Amphotericin B-conjugated polypeptide hydrogels as a novel innovative strategy for fungal infections.
P2860
Unmet clinical needs in the treatment of systemic fungal infections: The role of amphotericin B and drug targeting.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Unmet clinical needs in the tr ...... otericin B and drug targeting.
@en
Unmet clinical needs in the tr ...... otericin B and drug targeting.
@nl
type
label
Unmet clinical needs in the tr ...... otericin B and drug targeting.
@en
Unmet clinical needs in the tr ...... otericin B and drug targeting.
@nl
prefLabel
Unmet clinical needs in the tr ...... otericin B and drug targeting.
@en
Unmet clinical needs in the tr ...... otericin B and drug targeting.
@nl
P2093
P1476
Unmet clinical needs in the tr ...... otericin B and drug targeting.
@en
P2093
Esther de Pablo
María Paloma Ballesteros
Raquel Fernández-García
P304
P356
10.1016/J.IJPHARM.2017.04.013
P407
P577
2017-04-08T00:00:00Z